Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia (clinicaltrials.gov) - Sep 4, 2026 - P2 | N=10 | Active, not recruiting | Sponsor: M.D. Anderson Cancer Center | Trial completion date: Sep 2026 ➔ Sep 2028 | Trial primary completion date: Sep 2026 ➔ Sep 2028
Trial completion date • Trial primary completion date • Chronic Lymphocytic Leukemia • Fatigue • Hematological Malignancies • Leukemia • Lymphoma • Oncology
|